{"doi":"10.1158/2159-8290.22529738","title":"Supplementary Figures S1 - S2 from Measuring Residual Estrogen Receptor Availability during Fulvestrant Therapy in Patients with Metastatic Breast Cancer","abstract":"<jats:p>&lt;p&gt;Supplemental Figure S1. (A) Patient plasma fulvestrant levels at day 28 and 84 as measured by LC/MS/MS. (B) Patient serum estradiol (E2) levels at baseline, day 28 and 84, measured by fluorescent-immuno-assay and corrected for fulvestrant cross-reactivity. Supplemental Figure S2. Cross-reactivity between fulvestrant and estradiol (E2) fluorescent-immuno-assay.&lt;/p&gt;</jats:p>","journal":null,"year":null,"id":599101,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1535450,"name":"Elisabeth G. de Vries","orcid":null,"position":1,"is_corresponding":false},{"id":1535451,"name":"Andor W. Glaudemans","orcid":null,"position":2,"is_corresponding":false},{"id":1535452,"name":"Meta C. van Lanschot","orcid":null,"position":3,"is_corresponding":false},{"id":723356,"name":"Martijn van Faassen","orcid":"0000-0002-9142-6263","position":4,"is_corresponding":false},{"id":723358,"name":"Ido P. Kema","orcid":"0000-0003-1166-6169","position":5,"is_corresponding":false},{"id":443,"name":"Myles Brown","orcid":"0000-0002-8213-1658","position":6,"is_corresponding":false},{"id":1109376,"name":"Carolien P. Schröder","orcid":null,"position":7,"is_corresponding":false},{"id":1535453,"name":"Erik F. de Vries","orcid":null,"position":8,"is_corresponding":false},{"id":1535454,"name":"Geke A. Hospers","orcid":null,"position":9,"is_corresponding":false},{"id":1535449,"name":"Michel van Kruchten","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Supplementary Figures S1 - S2 from Measuring Residual Estrogen Receptor Availability during Fulvestrant Therapy in Patients with Metastatic Breast Cancer","abstract":"<jats:p>&lt;p&gt;Supplemental Figure S1. (A) Patient plasma fulvestrant levels at day 28 and 84 as measured by LC/MS/MS. (B) Patient serum estradiol (E2) levels at baseline, day 28 and 84, measured by fluorescent-immuno-assay and corrected for fulvestrant cross-reactivity. Supplemental Figure S2. Cross-reactivity between fulvestrant and estradiol (E2) fluorescent-immuno-assay.&lt;/p&gt;</jats:p>","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23304386","pmcid":null,"openalex_id":"https://openalex.org/W4362531227","authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://aacr.figshare.com/ndownloader/files/39992855","host_type":""},{"url":"https://aacr.figshare.com/ndownloader/files/39992855","host_type":""},{"url":"http://dx.doi.org/10.1158/2159-8290.22529738","host_type":""},{"url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_S1_-_S2_from_Measuring_Residual_Estrogen_Receptor_Availability_during_Fulvestrant_Therapy_in_Patients_with_Metastatic_Breast_Cancer/22529738","host_type":"repository"}],"fields_of_study":["Estrogen and related hormone effects"],"mesh_terms":[],"keywords":["Fulvestrant","Breast cancer","Metastatic breast cancer","Estrogen receptor","Internal medicine","Oncology","Medicine","Estrogen","Cancer","Endocrinology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-28T18:32:53.326164Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}